Prematogest Progesterone 250mg/ml Hormonal Support Injection 1s

• Long-acting progestogen injection for prevention of preterm birth and recurrent miscarriage • Provides sustained progesterone support for 7–10 days with one injection • Suitable for pregnant women with history of spontaneous preterm delivery or short cervix • Clinically proven to reduce preterm birth risk by up to 34% in singleton pregnancies • With hydroxyprogesterone caproate 250 mg/mL technology

Hydroxyprogesterone Caproate 250 mg/mL Solution for Injection (1 mL or 5 mL vials/ampoules) is a synthetic progestogen with prolonged action (depot preparation in castor oil). It is indicated for: Prevention of preterm birth in singleton pregnancy (16–20 weeks until 36 weeks) Threatened miscarriage and prevention of habitual abortion Luteal phase support in some fertility protocols Certain cases of amenorrhoea or endometrial issues The slow-release oil base ensures steady progesterone levels for 7–10 days after a single intramuscular injection. Benefits: • Significantly reduces risk of delivery before 37, 35, and 32 weeks • Proven effective in women with previous spontaneous preterm birth • Once-weekly dosing – excellent compliance • Well-established safety profile (used globally since 1950s) • Helps maintain pregnancy in progesterone-dependent threatened miscarriage How to use: • Test on small area of skin before use • Administered by deep intramuscular injection (usually 250 mg once weekly) by healthcare professional • For best results start at 16–20 weeks and continue until 36 weeks or delivery; rotate injection sites (upper outer quadrant of gluteus)